Ardan Equity and GI Partners take co-control of Clinical Ink
Monday, October 19, 2026 · first reported by PE Hub
Ardan Equity and GI Partners jointly acquired co-control of Clinical Ink, a provider of electronic clinical outcome assessment and connected device technology to pharmaceutical and contract research organizations.
- Firm
- Ardan Equity
- Also named
- Clinical Ink
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- EQT Infrastructure to acquire Australian waste management firm Cleanaway at $6.5bn valuationPE Hub +2
- KKR inks $2.9bn sale of railcar lessor Infinity Transportation to AresPE Hub
- Avenue Capital is top contender for stake in Serie A media rights businessPrivate Equity Wire
- Primary Health Properties and GIC form £700m private hospital joint ventureIPE Real Assets
- CVC’s Panzani in exclusive talks to merge with Sofina-backed CerealisPE Hub
- Banner Capital launches roofing platform with Exterior Solutions Group dealPE Hub